Effects of Vasoactive Intestinal Peptide on Osteoarthritis in Vivo and the Cultured Chondrocyte in Vitro and the Underlying Mechanism
Wang Hua,Jiang Wei,Zhang Xiaoming,Lyu Meng,Lin Bowen,Zhou Chukun
DOI: https://doi.org/10.3760/cma.j.issn.1001-9030.2018.04.038
2018-01-01
Abstract:Objective To investigate the treating-effect of vasoactive intestinal peptide (VIP) on osteoarthritis (OA) in vivo and the improving-effect on OA chondrocyte in vitro,then clarify the underlying mechanism.Methods The OA model on the SD rat knee was established by Hulth method,and the recombinant pcDNA3.1 ±/VIP plasmid was also constructed.After the VIP plasmid were injected intra-articularly into OA rats for 1 month,the pathological changes of OA knee joint were observed by Hematoxylin-eosin (HE) staining.The levels of serum cytokines [tumor necrosis factor-α (TNF-α),interleukin (IL)-1,IL-2 and IL-6] were measured by enzyme linked immunosorbent assay (ELISA) kits.Meanwhile,OA chondrocyte were cultured in vitro,and treated by plasmid VIP.The proliferation of chondrocyte was determined by cell counting kit-8 (CCK-8) kits.The protein expressions of collagen type I (Collagen Ⅰ),collagen type Ⅱ (Collagen Ⅱ) and nuclear factor (NF)-κB were evaluated by Western blotting.The mRNA expressions of matrix-degrading enzyme matrix metalloproteinase (MMP)-3 and matrix-degrading enzyme inhibitor tissue inhibitorof metalloproteinase (TIMP)-1 were determined by reverse transcriptase-polymerase chain reaction (RT-PCR).Results VIP plasmid could effectively improve the pathological state of the OA ratskneejoint.In addition,before the OA rats treated by VIP plasmid,the level of serumTNF-α,IL-1,IL-2 and IL-6 were (185.3±9.1),(391.7 ±20.6),(169.8 ± 10.8),(143.7 ±15.2) pg/ml;then treated by VIP plasmid the level of serum TNF-α,IL-1,IL-2 and IL-6 were (112.8 ±10.2),(298.2±15.9),(131.4 ±13.4),(81.6±13.4) pg/ml,the levels of serum cytokinesweresignificantly decreased.At the same time,the absorbance (A450 nm) of chondrocytein OA group and VIP-treat groupdeterminedby CCK-8 kit were 0.75 ± 0.12,1.38 ± 0.14,respectively,suggesting that after the OA chondrocytes treated by VIP plasmid,the proliferation was obviously increased.The MMP-3 mRNA expression of chondrocytesin OA group and VIP-treat group were 2.48 ± 0.24,1.35 ±0.16,respectively;the TIMP-1 mRNA expression were 0.56 ±0.11,0.85 ±0.09,respectively,suggesting that the MMP-3 expression was remarkably downregulated,and TIMP-1 expression was obviously upregulated by VIP plasmid.MAfer the the protein expression of Collagen Ⅰ,Collagen Ⅱ and NF-κB in were evaluated by Western blotting,we found that the expression of Collagen Ⅰ and NF-κB in chondrocyteswere decreased,and the expression of Collagen Ⅱ in chondrocyteswas increased by VIP plasmid.Conclusion VIP could treat osteoarthritisto some extent via inhibiting NF-κB signal pathway.